Health & Nutrition
Weight Management & GLP-1 Therapies
Weight management in 2025 is being revolutionized by GLP-1 therapies like Ozempic and Semaglutide, which have seen significant year-over-year growth. These drugs, which regulate appetite and blood sugar, are a key part of medical weight loss programs that combine pharmaceuticals with personalized nutrition, exercise plans, and behavioral coaching. The future of this field is moving toward personalized, AI-driven strategies, digital monitoring, and next-generation therapies, with a growing focus on a holistic approach that includes psychological well-being.